US EditionBiontech: Is a New Cancer Medication Coming Soon?
Summary by LVZ - Leipziger Volkszeitung
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
LVZ - Leipziger VolkszeitungReposted by 
KN - Kieler Nachrichten
KN - Kieler NachrichtenThe Mainz-based company Biontech has become known for its corona vaccine. In the future, however, the company wants to rely on cancer treatments. A cooperation with a US company already exists for this.
·Leipzig, Germany
Read Full Article
Mainz – The pharmaceutical company BioNTech, known for its COVID-19 vaccine, sees itself on track for the first approval for a cancer drug. The two central pillars of its oncology strategy were strengthened in the second quarter of 2025, said BioNTech CEO and co-founder Ugur Sahin. Sahin referred to the agreement reached in June...
The pharmaceutical company Biontech, known for its Covid vaccine, is on course towards a first authorisation for a cancer drug.
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
